淋巴瘤是常见的造血系统恶性肿瘤,近二十年来,联合放疗化疗不断进展,使淋巴瘤的治疗效果有了显著的提高,联合大剂量放/化疗和自体干细胞移植对复发难治的的何杰金式淋巴瘤(HD)和非何杰金式淋巴瘤(NHD)有潜在治愈的可能,也可作为有预后不良因素或化疗效果差的患者的一线治疗.近 Lymphoma is a common malignant tumor of hematopoietic system. In the recent two decades, the continuous progress of combined radiotherapy and chemotherapy has resulted in a significant improvement of the therapeutic effect of lymphomas. In combination with high-dose radiotherapy / chemotherapy and autologous stem cell transplantation, Jayden Lymphoma (HD) and Non-Hodgkin’s Lymphoma (NHD) have the potential to be cured as well as first-line therapy in patients with poor prognosis or poor response to chemotherapy.